"FDA"

Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.

The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.

Ten-year results show a single CAR T infusion can keep many patients with aggressive and slow-growing B-cell lymphomas cancer-free, pointing...

In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes progress safe.

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while...

In an interview hours before the U.S. government issued a directive to disable Anthropic’s newest AI model, the company’s Chief Commercial O...

A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients

Most people do not realize that AI has imbalances due to the initial training of the AI. This is worrisome for AI giving out mental health a...

Some use AI to find loopholes around legal and safety restrictions on AI mental health chats. An AI Insider analysis and scoop.

In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasi...

The uncomfortable part for healthcare providers isn’t that patients are asking AI. It’s that most providers have no idea whether the AI is r...

The parasite found in uncooked fresh produce contaminated with human feces has sickened thousands and hospitalized hundreds all over the U.S...